A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation

Researchers explored how the incorporation of N1-methylpseudouridine (1-methylΨ) into mRNAs affects ribosomal frameshifting and the overall fidelity of mRNA translation.

CureVac claims delay in German court over alleged infringement of its Covid-19 vaccine by BioNTech a sign in its favor

CureVac is expecting good news in its patent infringement cases for components of its Covid-19 vaccine against Pfizer partner BioNTech in Germany after a court

September 29, 2023

Acute On Chronic Liver Failure (ACLF) drugs in development, 2024

GlobalData tracks 15 drugs in development for Acute On Chronic Liver Failure (ACLF) by 11 companies/universities/institutes. The top development phase for Acute On Chronic Liver

August 31, 2024

AstraZeneca to withdraw Covid-19 vaccine globally

The new development follows the company’s voluntary withdrawal of marketing authorisation for the vaccine in the European Union. Credit: rarrarorro / Shutterstock.com. AstraZeneca has begun

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.